91高清自产国产拍,无码免费A级毛片大全,日本 欧美 国产中文字幕,99re热视频这里只有精品视频首页

Bardoxolone,诱导剂

规格或纯度: ≥98%
有货

库存信息

关闭

库存信息

关闭
货号 (SKU) 包装规格 是否现货 价格 数量
B125862-25mg
25mg 现货 Stock Image
B125862-100mg
100mg 期货 Stock Image

基本描述

规格或纯度 ≥98%
英文名称 Bardoxolone
别名 CDDO;RTA 401
英文别名 CDDO;RTA 401;RTA401;RTA-401;2-Cyano-3,12-dioxooleana-1,9-dien-28-oic acid
生化机理

Bardoxolone methyl, previously known as RTA 402, is the lead molecule in Reata's portfolio of Antioxidant Inflammation Modulators (AIMs). The AIMs are potent inducers of the transcription factor Nrf2, an important biological target that controls the production of many of the body's antioxidant and detoxification enzymes. Because oxidative stress and inflammation occur throμghout the course of chronic kidney disease (CKD) and are known to contribute to loss of kidney function, agents that activate the Nrf2 pathway in patients with CKD may provide a novel method for preserving or improving kidney function. Bardoxolone methyl is currently being investigated as a potential oral once-a-day treatment for CKD.

储存温度 -20°C储存
运输条件 超低温冰袋运输
备注 卖完停产,不再备货
产品介绍

Bardoxolone(RTA 402)是抗氧化炎症调节剂(AIM)的先导化合物,此类AIM是转录因子Nrf2诱导剂。

Bardoxolone(RTA 402) is the lead molecule in Reata's portfolio of Antioxidant Inflammation Modulators (AIMs). The AIMs are potent inducers of the transcription factor Nrf2.

名称和标识符

IUPAC Name (4aS,6aR,6bS,8aR,12aS,14aR,14bS)-11-cyano-2,2,6a,6b,9,9,12a-heptamethyl-10,14-dioxo-1,3,4,5,6,7,8,8a,14a,14b-decahydropicene-4a-carboxylic acid
INCHI InChI=1S/C31H41NO4/c1-26(2)10-12-31(25(35)36)13-11-30(7)23(19(31)16-26)20(33)14-22-28(5)15-18(17-32)24(34)27(3,4)21(28)8-9-29(22,30)6/h14-15,19,21,23H,8-13,16H2,1-7H3,(H,35,36)/t19-,21-,23-,28-,29+,30+,31-/m0/s1
InChi Key TXGZJQLMVSIZEI-UQMAOPSPSA-N
Canonical SMILES CC1(CCC2(CCC3(C(C2C1)C(=O)C=C4C3(CCC5C4(C=C(C(=O)C5(C)C)C#N)C)C)C)C(=O)O)C
PubChem CID 400010
分子量 491.66

化学和物理性质

溶解性 DMSO

关联配体

Ligand ID 2717
名称 bardoxolone
别名 CDDO
类别 Synthetic organic
学名 (4aS,6aR,6bS,8aR,12aS,14aR,14bS)-11-cyano-2,2,6a,6b,9,9,12a-heptamethyl-10,14-dioxo-1,3,4,5,6,7,8,8a,14a,14b-decahydropicene-4a-carboxylic acid
生物活性评价 The sulfonamide class of antibacterial compounds are primarily bacteriostatic agents and have a broad spectrum of activity against both Gram-positive and Gram-negative species of bacteria (reviewed in ).
评价 Bardoxolone was a Phase 3 NF-κB signaling inhibitor . Although the recommended INN for this compound is bardoxolone, it is administered as bardoxolone methyl which has ChEMBL ID CHEMBL1762621. Bardoxolone can be described as a KEAP1 antagonist, as it antigonises KEAP1 interaction with the Nrf2 transription factor . As this action releases Nrf2 from the inhibitory effect of the protein-protein interaction, it can also be described as a functional Nrf2 activator.

相关文档

质检报告COA

请输入批号:


产品问答

产品问答

登录提交问题 Hover me 请先登录再提交问题
您提交该产品问题后,我们会在1-2个工作日内给您答复,您可以登录"我的账号",然后点击"我的产品问答"查看答案

参考文献

1. Dinkova-Kostova AT, Liby KT, Stephenson KK, Holtzclaw WD, Gao X, Suh N, Williams C, Risingsong R, Honda T, Gribble GW et al..  (2005)  Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress..  Proc Natl Acad Sci USA,  102  (12):  (4584-9).  [PMID:15767573]
2. Rojas-Rivera J, Ortiz A, Egido J.  (2012)  Antioxidants in kidney diseases: the impact of bardoxolone methyl..  Int J Nephrol,  2012  (13):  (321714).  [PMID:22701794]
3. Wu J, Liu X, Fan J, Chen W, Wang J, Zeng Y, Feng X, Yu X, Yang X.  (2014)  Bardoxolone methyl (BARD) ameliorates aristolochic acid (AA)-induced acute kidney injury through Nrf2 pathway..  Toxicology,  318  (13):  (22-31).  [PMID:24530882]
4. Cleasby A, Yon J, Day PJ, Richardson C, Tickle IJ, Williams PA, Callahan JF, Carr R, Concha N, Kerns JK et al..  (2014)  Structure of the BTB domain of Keap1 and its interaction with the triterpenoid antagonist CDDO..  PLoS ONE,  (6):  (e98896).  [PMID:24896564]

91高清自产国产拍,无码免费A级毛片大全,日本 欧美 国产中文字幕,99re热视频这里只有精品视频首页

品牌简介

{转码主词}